Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin

Oncogene
April 25, 2005
Cited by 116

Abstract


Related Papers

No related papers found

Powered by citation graph analysis